GENETIC ANALYSES OF GENES IN PRESENILIN RELATED PATHWAYS
GENETIC ANALYSES OF GENES IN PRESENILIN RELATED PATHWAYS
批准号:
6201068
负责人:
RUDOLPH Emile TANZI
金额:
$22.37万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-08-31
关键词:
Alzheimer's disease amyloid proteins biotechnology cell line endopeptidases enzyme activity family genetics gene expression genetic screening genetic susceptibility genotype human genetic material tag linkage disequilibriums linkage mapping neural degeneration nucleic acid sequence pathologic process posttranslational modifications presenilin proteolysis single nucleotide polymorphism
中文摘要
早老素1和早老素2(PS1,PS2)都经历受调节的内切蛋白水解,
处理以产生两个稳定片段。我们最近发现,
PS1和PS2将在远离正常细胞的位点交替切割。
细胞凋亡过程中的切割位点,以及当转染细胞中过表达时,
细胞系凋亡相关的PS1和PS2的内蛋白水解可以是
被凋亡半胱氨酸蛋白酶抑制剂zVAD阻断,
半胱天冬酶抑制剂,和zDEVD,一种选择性半胱天冬酶-3(CPP 32)抑制剂,
表明起作用的酶是半胱天冬酶-3家族蛋白酶。我们
已经将PS2中的凋亡切割位点鉴定为DSYDS(a.a.(第326-330段)
通过定点诱变。支持细胞凋亡的潜在作用,
FAD中早老素的裂解,凋亡:正常裂解的比率
在表达FAD突变体的细胞中,
PS2-N141 I与w.t. PS2表达细胞。由于FAD突变,
PS1/PS2与A β 42:A β 40比率升高有关,
我们已经产生了初步的数据来测试是否抑制
caspase-3介导的突变型PS2的切割可以抑制突变型PS2的细胞增殖,
Abeta 42:与FAD突变相关的Abeta 40比率。zVAD治疗
抑制了A β 42:总A β比率的增加,
N141 I和M239 V FAD突变在PS2中减少44%。总的来说,这些发现
不仅表明早老素可能是细胞死亡底物,
caspase 3家族蛋白酶对早老素的非凋亡裂解
可能改变A β 42:A β 40比值,并在发病机制中发挥作用
的FAD。鉴于这些新的发现,我们将测试以下内容
假设:1.早老素FAD突变导致细胞凋亡增加-
caspase-3家族对早老素的相关内蛋白水解
蛋白酶; 2.早老素的凋亡相关裂解导致
增加的A β 42:A β 40比率;和4.细胞凋亡内蛋白水解
早老素改变亚细胞分布和/或分子水平,
早老素的相互作用。
英文摘要
Presenilin 1 and 2 (PS1, PS2) both undergo regulated endoproteolytic
processing to yield two stable fragments. We have recently discovered that
PS1 and PS2 will be alternatively cleaved at sites distal to the normal
cleavage sites during apoptosis, and when over-expressed in transfected
cell lines. Apoptosis-associated endoproteolysis of PS1 and PS2 can be
blocked by the apoptotic cysteine protease inhibitors, zVAD, a general
caspase inhibitor, and zDEVD, a selective caspase-3 (CPP32) inhibitor,
indicating that the enzyme responsible is a caspase-3 family protease. We
have identified the apoptotic cleavage site in PS2 as DSYDS (a.a. 326-330)
by site directed mutagenesis. In support of a potential role for apoptotic
cleavage of the presenilins in FAD, the ratio of apoptotic:normal cleavage
fragments was elevated by over 3-fold in cells expressing the FAD mutant
PS2-N141I as compared to w.t. PS2-expressing cells. Since FAD mutations in
PS1/PS2 have been associated with an elevated ration of Abeta42:Abeta40,
we have generated preliminary data to test whether inhibition of the
caspase-3 mediated cleavage of mutant PS2 could repress the increased
Abeta42:Abeta40 ration associated with FAD mutations. Treatment with zVAD
repressed the increases in Abeta42:total Abeta ratio associated with the
N141I and M239V FAD mutations in PS2 by 44%. Collectively, these findings
not only suggest that the presenilins may be cell death substrates, but
not apoptotic cleavage of the presenilins by a caspase 3 family protease
may alter the Abeta42:Abeta40 ration and play a role in the pathogenesis
of FAD. In view of these novel findings, we will test the following
hypotheses: 1. Presenilin FAD mutations lead to increased apoptosis-
associated endoproteolysis of the presenilins by a caspase-3 family
protease; 2. Apoptosis-associated cleavage of the presenilins leads to an
increased Abeta42:Abeta40 ratio; and 4. Apoptotic endoproteolysis of the
presenilins alters the subcellular distribution and/or molecular
interactions of the presenilins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of Alzheimer's Mutations in ADAM10.
-
批准号:8890722
-
项目类别:
-
资助金额:$33.54万
-
财政年份:2012
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Characterization of Alzheimer's Mutations in ADAM10.
-
批准号:8438141
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Characterization of Alzheimer's Mutations in ADAM10.
-
批准号:8550747
-
项目类别:
-
资助金额:$32.68万
-
财政年份:2012
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Characterization of Alzheimer's Mutations in ADAM10.
-
批准号:8721305
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2012
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
GENETIC ANALYSES OF GENES IN PRESENILIN RELATED PATHWAYS
-
批准号:7483171
-
项目类别:
-
资助金额:$47.11万
-
财政年份:2007
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Alzheimer's Disease Genes, Cellular Pathways and Therapies
-
批准号:7001149
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2005
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
ACAT inhibitors regulate palmitoylated APP and Abeta production
-
批准号:9058612
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
-
批准号:10451563
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
-
批准号:9920896
-
项目类别:
-
资助金额:$5.11万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
-
批准号:10210441
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
ACAT inhibitors regulate palmitoylated APP and Abeta production
-
批准号:8631103
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
Role of MAMs in stabilization and BACE1-mediated processing of palAPP.
-
批准号:9790978
-
项目类别:
-
资助金额:$40.89万
-
财政年份:2002
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
CORE--TISSUE CULTURE, REAGENTS, AND ELISA
-
批准号:6345908
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2000
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
GENETIC ANALYSIS OF ALZHEIMERS DISEASE
-
批准号:6314325
-
项目类别:
-
资助金额:$27.73万
-
财政年份:2000
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
ALTERNATIVE CASPASE MEDIATED CLEAVAGE OF THE PRESENILINS
-
批准号:6345905
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2000
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
CORE--GENETICS
-
批准号:6336181
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2000
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
GENETIC ANALYSIS OF ALZHEIMERS DISEASE
-
批准号:6295358
-
项目类别:
-
资助金额:$27.73万
-
财政年份:1999
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
GENETIC ANALYSIS OF ALZHEIMERS DISEASE
-
批准号:6098029
-
项目类别:
-
资助金额:$27.73万
-
财政年份:1999
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
CORE--TISSUE CULTURE, REAGENTS, AND ELISA
-
批准号:6201071
-
项目类别:
-
资助金额:$22.37万
-
财政年份:1999
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
SEARCH FOR NOVEL ALZHEIMERS DISEASE GENES
-
批准号:6392515
-
项目类别:
-
资助金额:$54.32万
-
财政年份:1999
-
负责人:RUDOLPH Emile TANZI
-
依托单位:
海外基金